Pharbest Aspirin 325mg

Product NDC: 16103-357
11-digit product format: 161030357
Labeler code: 16103
Product ID: 16103-357_6e358e1f-41e4-4b47-9546-935cd46a98a5
Type: HUMAN OTC DRUG
Nonproprietary name: Aspirin
Dosage form: TABLET, DELAYED RELEASE
Route: ORAL
Labeler: Pharbest Pharmaceuticals, Inc.
Application: part343
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2010-09-20
Marketing end: 0000-00-00
Substance: ASPIRIN
Active strength: 325 mg/1
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	16103-357		I	Inactivated by FDA	2026-10-05
excluded package	package	16103-357	16103-357-08	I	Inactivated by FDA	2026-10-05
excluded package	package	16103-357	16103-357-11	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 51 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	16103-357-11	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	16103-357-08	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	16103-357-11	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	16103-357-08	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	16103-357-11	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	16103-357-08	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	16103-357-11	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	16103-357-08	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	16103-357-11	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	16103-357-08	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	16103-357-11	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	16103-357-08	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	16103-357-11	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	16103-357-08	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	16103-357-11	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	16103-357-08	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	16103-357-11	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	16103-357-08	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	16103-357-11	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	16103-357-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	16103-357-11	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	16103-357-08	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	16103-357-11	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	16103-357-08	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	16103-357-11	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	16103-357-08	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	16103-357-11	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	16103-357-08	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	16103-357-11	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	16103-357-08	`1332a3947898…`	`d4bfe170f9cd…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	16103-357-11	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	16103-357-08	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	16103-357-11	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	16103-357-08	`9bebd1f3094a…`	`5416666fcb17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fb7ab793-2c12-4079-b100-a64f73bef25a	Product name	4	20240712
b0cbf770-6cc3-4aa4-9158-755110c2b9f7	Product name	2	20230717
dc7c5daa-021f-40dd-b00d-63982cb2067a	Product name	1	20230426
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	5	20200925
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	2	20160823
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
16103-357-08	2023-01-30	Drug Facts
16103-357-11	2023-01-30	Drug Facts
16103-357-08	2021-03-30	Drug Facts
16103-357-11	2021-03-30	Drug Facts
16103-357-08	2020-01-31	Drug Facts
16103-357-11	2020-01-31	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
16103-357-08	Pharbest Aspirin 325mg	1 in 1 CARTON	TABLET, DELAYED RELEASE	1	2
16103-357-08	Pharbest Aspirin 325mg	100 in 1 BOTTLE	TABLET, DELAYED RELEASE	100	2
16103-357-11	Pharbest Aspirin 325mg	1000 in 1 BOTTLE	TABLET, DELAYED RELEASE	1000	2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
16103-357-08	EA - Each	16103-357	7b6abbbb-4a1a-40f5-b443-15fe8f754bf5	1	2014-10-03
16103-357-11	EA - Each	16103-357	0981b14e-f5c1-45fb-a390-cfd92a563831	1	2014-10-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
D&C RED NO. 6	INACTIVE INGREDIENT	481744AI4O	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
D&C RED NO. 6	INACTIVE INGREDIENT	481744AI4O	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)	INACTIVE INGREDIENT	74G4R6TH13	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)	INACTIVE INGREDIENT	74G4R6TH13	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
16103-357	PHARBEST ASPIRIN 325MG (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	2	Legacy NDC, 3 package rows	20210331_7b505734-2ed3-4916-9fff-f7128391cf23.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
198467	aspirin 325 MG Delayed Release Oral Tablet	PSN	7b505734-2ed3-4916-9fff-f7128391cf23	2
198467	aspirin 325 MG Delayed Release Oral Tablet	SCD	7b505734-2ed3-4916-9fff-f7128391cf23	2
198467	ASA 325 MG Delayed Release Oral Tablet	SY	7b505734-2ed3-4916-9fff-f7128391cf23	2
198467	aspirin 325 MG Enteric Coated Oral Tablet	SY	7b505734-2ed3-4916-9fff-f7128391cf23	2
198467	aspirin 325 MG Delayed Release Oral Tablet	PSN	59c703f4-328a-44fa-e053-2991aa0a3e2e	1
198467	aspirin 325 MG Delayed Release Oral Tablet	SCD	59c703f4-328a-44fa-e053-2991aa0a3e2e	1
198467	ASA 325 MG Delayed Release Oral Tablet	SY	59c703f4-328a-44fa-e053-2991aa0a3e2e	1
198467	aspirin 325 MG Enteric Coated Oral Tablet	SY	59c703f4-328a-44fa-e053-2991aa0a3e2e	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
16103-357-08	16103035708	1 BOTTLE in 1 CARTON (16103-357-08) > 100 TABLET, DELAYED RELEASE in 1 BOTTLE	1 bottle	2010-09-20	0000-00-00	No	No	Current
16103-357-11	16103035711	1000 TABLET, DELAYED RELEASE in 1 BOTTLE (16103-357-11)		2010-09-20	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Drug Facts	Pharbest Pharmaceuticals, Inc.	2021-01-12	HUMAN OTC DRUG LABEL	2
Drug Facts	A-S Medication Solutions	2019-04-01	HUMAN OTC DRUG LABEL	11
169 Aspirin Enteric Coated 325 mg Drug Facts	Contract Pharmacy Services-PA \| Coupler Enterprises	2017-09-22	HUMAN OTC DRUG LABEL	1